Professional Documents
Culture Documents
Bringing Health Care To Your Fingertips Ahead of The Curve Series
Bringing Health Care To Your Fingertips Ahead of The Curve Series
Research
Charles Rhyee
646.562.1376
charles.rhyee@cowen.com
James Auh
646.562.1352
james.auh@cowen.com
Zachary Wachter
646.562.1353
zachary.wachter@cowen.com
www.cowen.com
Equity Research
Industry Overview
www.cowen.com
Investment Summary
The terms telehealth and telemedicine are often used interchangeably, but both
describe the use of medical information exchanged from one site to another via
electronic communications to improve the patients health status. In this report, we
look at the evolution of telehealth towards a broader means of delivering healthcare
services in an on-demand, consumer-centric manner. We believe telehealth is about
to break into the mainstream as a confluence of recent regulatory and technological
disruption has enabled telehealth to benefit from the fast evolving healthcare
landscape. In particular:
Health reform represents a positive tailwind as millions of new lives are added to an
already cost-burdened system generating greater demand for lower-cost services
such as telehealth.
Recent legislation has made telehealth a more viable option for providers by
relaxing regulations against its use and improving associated licensure standards
and reimbursement in its favor.
Technology has evolved to the point where smartphones are ubiquitous, enabling
services such as healthcare to be delivered to consumers fingertips at a moments
notice.
As the U.S. health system transitions from a fee-for-service model to a fee-foroutcomes model, we see telehealth being embraced by providers, payors, employers
and consumers. Further, we believe the recent push into telehealth from all
stakeholders is part of the wider digital health movement encompassing clinical
analytics and Big Data, consumer engagement technologies, wearables and
biosensing, and population health management. While there are limited direct
investment ideas for investors today, except perhaps in the area of remote patient
monitoring (ex., Medtronic and possibly Dexcom), we believe investors should begin
to pay attention as we expect telehealth to not only be directly investable in the
relatively near future, but also to play an important strategic role for other constituents
in healthcare, including medical device, diagnostics, managed care, providers and
drug retailers.
In this report, we largely focus on the delivery of healthcare services in an on-demand,
consumer-centric manner. We see the larger near-term opportunity for telehealth
companies geared more towards general practice over specialist care. Leading
telehealth service companies, such as American Well, Teladoc, and MDLive, remain at
the forefront of this movement to on-demand, consumer-centric healthcare. We
estimate the total addressable market for outpatient spending on conditions currently
treated by telehealth is approximately $57 billion (Figure 2). Furthermore, we see an
additional $125 billion in the total addressable market for conditions telehealth could
address in the future, including the management of chronic diseases. Assuming a 10%
penetration rate, this would put the market opportunity for currently treated conditions
at $5.7 billion and the additional potentially treatable conditions at $12.5 billion. In
general, we think successful telehealth players will be able to deliver on two broad
characteristics:
A strong consumer experience thats able to deliver the right care at the right time.
Higher out-of-pocket costs will make consumers more selective of how they
purchase healthcare services.
www.cowen.com
A compelling business case to providers, payors and employers, who we see as the
primary purchasers of services from telehealth companies. Successful telehealth
players will be able to demonstrate strong ROI in the areas of brand extension,
market reach, and customer acquisition and retention.
We have already begun to see telehealth become a part of the strategy of companies
inside and outside our coverage universe, including:
Health plans: UNH currently has 16 telehealth partners they work with outside
physicians offices, and is already managing upwards of 350,000 telehealth
consultations a day including 20,000 people remotely monitored in their homes.
HUM has a pilot program for 100 seniors enrolled in its Medicare Advantage plans,
whereby through the use of in-home sensors and remote monitoring technology
elderly patients can remain in their homes longer on their own. ANTM recently
launched a new online service, LiveHealth Online in partnership with American
Well, which it expects to roll-out nationally to its 33 million members.
Providers: As early as 2009, UHS implemented a telemental health program at
Anchor Hospital near Atlanta to reach the behavioral needs of remote communities
nearby, which has now expanded to general telemedicine services for hospital ERs
and nursing homes throughout Georgia. KND uses remote monitoring for a number
of its home-care patients, who have seen readmission rates consistently below state
and national averages. CYH and THC are members of a consortium of healthcare
companies that founded the Heritage Group, a VC firm that led a round of
investment in MDLive in early 2014.
Drug retailers: WBA recently announced a partnership with MDLive, which will offer
virtual consultations through Walgreens smartphone app. WBA also recently
announced a partnership with WebMD to offer a virtual wellness-coach. RAD has
formed a partnership with HealthSpot to pilot its telehealth kiosks in some of RADs
Ohio stores. CVS has been piloting telehealth in some of its MinuteClinic locations.
Traditional Healthcare IT: MDRX was one of the first major HCIT vendor to integrate
telehealth capabilities into its EHR when it announced a partnership with American
Well in 2012 enabling providers to document online voice and video telehealth
interactions into the EHR. Privately-held Epic has partnered with AMC Health to
integrate its telehealth solution into Epics EHR.
What Is Telehealth?
According to the Center for Connected Health Policy, telehealth is defined as a
collection of means or methods for enhancing health care, public health, and health
education delivery and support using telecommunications technologies. Telehealth
has the potential to provide better quality and more appropriate care for each patient,
as well as more efficient use of healthcare resources by potentially reducing the need
for expensive hospital care. Or more simply, telehealth expands access to care at
lower cost. While the definitions of the various categories within telehealth are very
fluid and sometimes cross borders, we would generally categorize telehealth into the
following domains:
Real-Time Interaction (Synchronous): Live, two-way interaction between a person
and a provider using audiovisual telecommunications technology. This can either be
done through traditional videoconferencing (more synonymous with traditional
www.cowen.com
www.cowen.com
1870 1880
1890
1900 1910
1920
1930 1940
1950
1960
NOW
www.cowen.com
Figure 2 . Total Addressable Market for Current and Potential Telehealth Conditions, 2012
35,000
Current Telehealth Conditions
Potential Telehealth Conditions
Other Conditions
30,000
Hypertension
$13.4B
Osteoarthritis
$27.1B
COPD,
asthma
$14.1B
Acute
bronchitis &
URI
$6.6B
25,000
Mental
disorders
$24.2B
20,000
Skin
disorders
$17.3B
Diabetes
$13.2B
15,000
Back
problems
$22.4B
Heart
conditions
$19.2B
Cancer
Infectious
diseases
10,000
Flu
$0.8B
Upper GI
disorder
$5.8B
Otitis
media
$2.4B
UTI
$1.6B
5,000
Sexual
health
$6.3B
Thyroid
disease
Headache
$3.7B
Allergic reactions
Glaucoma $2.1B
Pneumonia
Intestinal infection
$0.8B
0
1
Cerebrovascular
disease
Anemia
This significant market opportunity has not gone unnoticed by the venture community,
which has poured significant dollars into telehealth specifically and digital health more
broadly. According to Rock Health, telehealth funding saw 315% y/y growth in 2014,
as licensing and reimbursement have become increasingly favorable for the industry,
to reach $285 million making it the fastest growing segment in digital health in 2014
(Figure 3).
www.cowen.com
The growth of funding for telehealth mirrors the broader growth in Digital Health
technology services, encompassing clinical analytics and Big Data, consumer
engagement technologies, wearables and biosensing, and population health
management. The overall space has seen huge demand, exhibited by the over $4.1
billion in venture capital funding received by U.S. Digital Health companies, of deals
over $2 million, in 2014. This is almost as much funding as the space received in the
last three years combined and represents 125% y/y growth in funding relative to 2013.
Funding in Digital health has seen a CAGR of 45% from 2011-2014 (Figure 4).
Figure 4 . U.S. Digital Health Venture Capital Funding From 2011-2014
www.cowen.com
Competitive Landscape
Telehealth is very much an emerging and fragmented industry with numerous players
within various subsectors. In Figure 5, we outline largely pure-play telehealth
companies within their respective subsectors. While this outline is not all
encompassing, we believe it provides a general overview of the market.
10
www.cowen.com
Subse c tor
24/7 Virtual, OnDemand Doctor Visits
Teledermatology
De sc r iption
The use of phone or secure online video to
provide virtual, on-demand patient consultations
with Board Certified physicians for the diagnosis
and treatment of non-emergency or chronic
medical issues
The use of telecommunication technologies for
the diagnosis, consultation and treatment of
dermatological conditions and tumors of the skin
Telepsychiatry
Teleneurology
Teleradiology
www.cowen.com
11
12
www.cowen.com
Projected
20%
15%
10%
5%
2020
2018
2016
2014
2012
2010
2008
2006
2004
2002
2000
1998
1996
1994
1992
1990
1988
1986
1984
1982
1980
1978
1976
1974
1972
1970
1968
1966
1964
1962
0%
1960
Equity Research
Telehealth Has Already Demonstrated Clinical Efficacy On Both Cost And Quality
Two of telehealths most frequent use cases involve chronic and acute patient
settings, which make up a major portion of current healthcare costs that could be
better managed with telehealth solutions. A number of peer-reviewed clinical studies
have already demonstrated telehealths effectiveness in reducing healthcare costs,
while at the same time improving patient outcomes.
Cost Effectiveness Of Telehealth
A number of recent studies have concluded telehealth solutions save patients,
providers and payors money when compared to traditional approaches to care. In a
study done at Albuquerque, New Mexico-based Presbyterian Healthcare Services, the
Hospital at Home model taken from Johns Hopkins School of Medicine was applied
to provide hospital-level acute care to the home, in part through remote patient
monitoring. Patients in this study displayed comparable or better clinical outcomes to
similar patients treated in the hospital, as well as reported higher levels of satisfaction.
This program saved 19% for Medicare Advantage and Medicaid patients with
common acute care diagnoses over similar inpatients. Savings were generated mostly
from lower average length of stay and fewer lab and diagnostic tests than hospital
inpatients (Cryer, Shannon et. al, 2012).
In looking at how integrated telehealth could produce savings for Medicare patients
with chronic diseases, another study found integrating remote patient monitoring with
care management found significant savings. Against controls, these Medicare
beneficiaries using the telehealth tool realized savings of 7.7%-13.3% ($312-$542) per
person per quarter. This study suggests the ability to better coordinate care for
chronically ill patients via telehealth can be highly effective (Baker, Johnson et. al,
2011).
www.cowen.com
13
Quality Of Care
Clinical studies have similarly proven that telehealth solutions that allow for remote
monitoring of patients with chronic diseases or help expand the reach of specialists
result in comparable or improved care. In a meta-analysis of 29 studies on the effect
of home telehealth on clinical outcomes, telehealth was found to have a moderately
positive and statistically significant effect on outcomes. More detailed analysis
indicated telehealth solutions had positive significant effects for treatment of heart
disease and psychiatric conditions (Dellifraine and Dansky, 2008). Overall the metaanalysis indicated telehealth positively impacted clinical outcomes across disparate
patient populations.
Additional Case Studies
The United States Department of Veteran Affairs (VA) is recognized as one of the
world leaders in telehealth, having developed a home telehealth program more than a
decade ago. In 2012, the VA specific Telehealth Applications provided care from 150
VA medical centers and 750 community based outpatient clinics to over 485,000
patients and completed nearly 1.4 million telehealth consultations. The VAs home
telehealth program reported a 53% reduction in bed days of care, a 30% reduction in
hospital admissions, a travel reduction savings of $34.45 per consultation, and savings
of $1,999 per patient on an annual basis. Interestingly, the VA also reported a mean
score of 86% in patient satisfaction.
The United Kingdoms Department of Healths Whole System Demonstrator program,
launched in 2008, generated favorable results as well. The 12-month study involved
179 general practices in three areas in England and 3,230 patients with diabetes,
chronic obstructive pulmonary disease (COPD), or heart failure. The study included
1,584 control patients and 1,570 intervention patients. Intervention participants
received a package of telehealth equipment and monitoring services for 12 months.
The results showed that intervention participants were admitted to the hospital less
often (42.9% of intervention patients versus 48.2% of control patients) and significantly
fewer of them died (4.6% of intervention patients versus 8.3% of control patients). The
intervention group also had 0.54 emergency admissions per head, compared to 0.68
amongst control group participants. Additionally, tariff costs per head were 188 lower
for intervention participants.
Telehealth May Help To Truly Engage The Healthcare Consumer
The rise of the healthcare consumer has been driven primarily by the increasing cost
of healthcare. Patients have been forced to become healthcare consumers as the
relative cost burden of healthcare has shifted from employers to employees through
the proliferation of high-deductible, consumer-directed health plans (CDHPs). These
allow employers to fix their healthcare contribution and reduce their risk exposure. But
while employers are shifting the cost burden onto employees, at the same time they
want to give employees tools to succeed in the new healthcare landscape. An
example would be Castlights transparency tool that empowers employees to make
more informed purchasing decisions. According to a 2015 survey by the National
Business Group on Health and Towers Watson, up to 2/3 of employers in 2014 began
to use incentives to reward or penalize employees based on whether they participate
in workplace wellness programs. We see additional pressures on employers to move
more employees towards high deductible plans in coming years, particularly as the
Cadillac Tax is looming on the horizon set to take effect in 2018, which will penalize
employers for having high-cost medical plans beyond certain thresholds.
14
www.cowen.com
The net result of this shift towards CDHPs is that consumers are now paying 90%
more for healthcare than they did ten years ago. Data from the Commonwealth Fund
concluded that premium and out-of-pocket cost growth far outstrips the recent rise in
workers wages. As a result, high deductibles may lead many patients to forego care
and avoid filling prescriptions. According to data from the Kaiser Family foundation, as
many as one in four Americans skip some care due to the high cost they must bear.
As deductibles continue to rise, we think it incentivizes consumers to become more
price-conscious as well as more engaged in their care.
But for all the talk about the healthcare consumer and consumer-directed healthcare,
we have not seen meaningful consumer engagement with their health. This is because
in large part healthcare doesnt look like a consumer product, nor is it structured in a
format that is easy for consumers to engage. We believe todays telehealth solutions,
along other solutions such as mHealth and wellness platforms, could help improve
consumer engagement. Recent data suggests that consumers will increasingly use
telehealth solutions given their convenience and cost effectiveness. A recent Anthem
market survey found that 74% of consumers indicated they would use telehealth
services if available. We expect this number to increase as more baby boomers retire
and millenials become increasingly engaged in their healthcare. While many observers
see demand for telehealth primarily being driven by this older baby boomer
demographic most at risk for chronic conditions or others in rural locations with
limited access to care, we see a growing retail market for telehealth amongst
millenials who have grown up in the on-demand world of Amazon.
We see this further supported by a recent 2015 consumer survey from American Well,
which noted interest in telehealth was highest amongst 18-44 year olds, though
overall interest spanned across all age groups. The survey also noted that the primary
reason consumers would use telehealth was for convenience. Additionally, a report
from Salesforce.com called the 2015 State of the Connected Patient found that 60%
of millenials support the use of telehealth in place of physician visits and 71% would
like their provider to use an app to schedule appointments, review data and actively
manage their well-being. With new mobile device apps such as Apples HealthKit that
will integrate with Epics EMR recently coming out, we see millenials growing
increasingly engaged in their healthcare. In 2012, more than 13,000 mobile health
apps for consumers were available from the Apple App Store at an average cost of
just $3.21. Mobile apps such as American Wells AmWell app also give consumers the
ability to select which physician they would like to use from a number of options with
their credentials on demand (Figure 7). Based on American Wells consumer survey,
this is a valuable aspect of telehealth for consumers, as 88% would prefer to select
their physician rather than be randomly assigned.
www.cowen.com
15
Telehealth can improve outcomes and efficiencies by managing care outside of the
traditional healthcare setting, such as hospitals and clinics. By monitoring and
communicating with patients between visits or post-discharge through remote patient
monitoring, telehealth consultations and consumer health engagement websites,
healthcare providers should be better informed to provide the most clinically
appropriate and financially viable option for the patient as well as drive efficiencies by
reducing clinical waste. This means of monitoring and engaging the consumer should
also enable healthcare providers to intervene when appropriate. Telehealth and
remote patient monitoring will find synergies with the tidal wave of inexpensive and
user friendly wearable devices, which will emit data to the cloud through which
healthcare providers can collect and analyze the data.
Furthermore, remote patient monitoring should also enable healthcare providers to
measure and manage the adherence of prescriptions, as well as ensure patients are
not experiencing harmful side effects. Not only is this critical given 30% of
prescriptions written in the U.S. are not filled, but it allows payers and providers to
demonstrate improved outcomes. Additionally, results from a recent American Well
survey suggest at least 70% of consumers would rather have an online video visit to
obtain a prescription than travel to their doctors office. In addition, consumer health
engagement websites and telehealth services should drive further healthier outcomes,
16
www.cowen.com
as they provide a platform for patients to speak with healthcare providers outside of
the traditional healthcare setting.
Demand For Telehealth Is Growing From Major Stakeholders
As a result of the shifting healthcare landscape from reform and the demographic
shifts underway in the U.S., the use of telehealth is quickly becoming an imperative for
all healthcare stakeholders. We see demand for telehealth services coming from
various constituents in healthcare.
Payors
We believe the use of telehealth services will find meaningful interest from payors,
given the opportunity to lower costs through its use. For example, a problem of access
that telehealth helps solve is best displayed by misuse of the ER. According to a 2012
study by the American College of Emergency Physicians, 85% of Americans who
visited the ER said they couldnt wait to see their regular medical provider and 50%+
of visits were for non-emergency issues. Large payors, such as Unitedhealth, have
increasingly focused on telehealth solutions in order to bend the cost curve as the
nations healthcare system moves towards more performance-based reimbursement
over the next five years. UNH currently has 16 telehealth partners they work with
outside physicians offices. The company is already managing upwards of 350,000
telehealth consultations a day, adding up to billions of transactions per year. This
includes 20,000 people remotely monitored in their homes per day. While this is
meaningful progress for telehealth amongst payors, we note UNH is one of the more
progressive insurers leaving a large runway for growth in telehealth services.
Humana has discussed in the past how it sees technologies such as telehealth
flattening the healthcare delivery system by increasing the access points to care
along the care continuum, which enables the consumer to be both better educated
and receive a better care experience. HUM has an ongoing pilot program for 100
seniors enrolled in its Medicare Advantage plans. HUM notes the pilot will measure
the impact in-home sensors and remote monitoring technology have on improving
health outcomes and reducing frailty and fall-related hospital admissions for Medicare
members with chronic health conditions. HUM has also developed a larger scale
remote monitoring program for 2,000 elderly patients with congestive health failure in
33 states. In less than a year, this program has enabled HUM to reach remote patients
that would have otherwise gone unmonitored or treated. Encouragingly, 94% of these
patients found the platform easy to use and 93% said they would recommend it.
Anthem also recently launched a new online care service, LiveHealth Online, in
partnership with American Well, which it expects to roll-out nationally to its 33 million
members. This service is a 24/7 telehealth service available to anyone for $49 per
online visit and to many commercially-insured ANTM members for about $20. Early
users of the service have reported an average savings of $71 per visit, while also
saving most patients 2 to 3 hours per visit spent traveling to a physicians office. Other
insurers such as Aetna and Cigna have also started offering telehealth services, with
nationwide e-visits. AET has covered telemedicine services for most of the past
decade including all primary care physicians and about 30 specialties in its program.
CI also started offering the services on a broader basis more recently to self-insured
clients through a partnership with MDLive.
Employers have similarly noted the need to increase use of telehealth services to
contain costs as those who bear the risk of employee healthcare consumption seek
lower cost, more convenient alternatives to ER and urgent care visits. Additionally, the
www.cowen.com
17
www.cowen.com
19
mandating that diagnosis and treatment of a patient using telehealth should be held
to the same standards of care as traditional, in-person interactions.
Licensure
This issue of licensure portability has also been a hindrance to the adoption of
telehealth, however this barrier may be diminishing. Currently, there are ten state
medical boards that issue special licenses or certificates related to telehealth. These
licenses allow an out-of-state provider to render telehealth services in a state where
they are not located, or allow a provider to render services via telehealth in a state if
certain conditions are met, such as agreeing not to open a medical office in that state.
Furthermore, on September 5, 2014, the FSMB released the final version of their
proposal of Interstate Medical Licensure Compact (Compact) language (Figure 8). The
goals of the Compact are to develop a comprehensive process that complements
exiting licensing and regulating authority of state boards, ensure the safety of patient
and enhance the portability of a medical license, while providing a streamlined
process that allows physicians to become licensed in multiple states. Amongst the
largest hindrance regarding licensure for telehealth providers is the length of time the
process takes to receive a license in another state. The Compact would modernize and
streamline medical licensing while maintaining state oversight, accountability and
patient safety, more specifically it would expedite the interstate licensing process by
streamlining some of the repetitive aspects such as having information such as
medical education and results of examinations not have to be primary source verified
again if the physician was already primary source verified by the principal state of
license (Figure 9). Recently, the legislative chambers of South Dakota, Utah and
Wyoming passed the Compact. We expect more states to follow as ten other states
have formally introduced the legislation in their legislative chambers and more than 25
state medical and osteopathic boards have publicly expressed support for the
Compact.
Figure 8 . FSMB Interstate Medical Licensure Compact Application Process
Physician files
application for
expedited license w/
board of state of
principal license
Board of state of
principal license
evaluated if physician
eligible for expedited
license & issues
qualification letter
20
www.cowen.com
After verification,
physician completes
interstate commission
registration process
for license of member
state (fees paid)
After receiving
verification of
eligibility & any fees
paid, member board
issues expedited
license to physician
21
Sta te
Vi de o
Co nfe r e nci ng
Sto r e -a ndFo r w a r d
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
R e m o te Pa ti e nt
M o ni to r i ng
Sta te
Vi de o
Co nfe r e nci ng
Montana
Nebraska
Nevada
New Jersey
X
X
New York
Delaware
North Carolina
District of Columbia
North Dakota
Florida
Ohio
Georgia
Oklahoma
Hawaii
Oregon
Pennsylvania
Idaho
X
X
Indiana
X
X
X
X
Rhode Island
X
Iowa
Kansas
R e m o te Pa ti e nt
M o ni to r i ng
New Hampshire
New Mexico
Illinois
Sto r e -a ndFo r w a r d
South Carolina
South Dakota
Tennessee
Texas
Utah
Kentucky
Louisiana
Maine
Vermont
Maryland
Virginia
Washington
Michigan
West Virginia
Massachusetts
Minnesota
Wisconsin
Mississippi
Wyoming
Missouri
X
X
X
Private Payors
While there is no federal law mandating private payors to provide coverage for
telehealth services, some states, recognizing the benefits, have passed legislation that
require private payors to provide plans that reimburse at least some form of telehealth.
Currently, 21 states and the District of Columbia require private payor reimbursement.
Some states mandate reimbursement equivalent to comparable in-person care,
while other states just require some level of reimbursement. Currently, 21 states and
the District of Columbia require private insurance plans to cover telehealth services
(Figure 11).
Furthering the momentum, New York recently passed legislation mandating that
private insurers provide reimbursement for telehealth services, effective January 1,
2016. In addition, other states, such as Indiana and Iowa, are considering passing
similar laws, while other states, such as Oregon, are advocating for legislation to
expand existing telehealth coverage. Oregon lawmakers are pushing for the passage
22
www.cowen.com
of legislation that would provide health insurance coverage to patients who receive
telehealth services in any form and not just if it took place at a medical facility, as it
currently stands.
Meanwhile, some private payors are taking matters into their own hands and
providing reimbursement for telehealth services regardless of whether the state
requires it. For instance, Horizon Blue Cross Blue Shield of New Jersey announced the
creation of Horizon CareOnline, a telehealth service offering online video conferencing
to a physician 24 hours a day, seven days a week at no cost to its individual plan
members through American Well. Self-insured employers are deploying telehealth
solutions as well, recognizing its benefits.
Figure 11 . States with Medicaid and Private Insurance Reimbursement for Telehealth Services
23
24
www.cowen.com
Lung condition
68%
Cancer
62%
57%
Diabetes
50%
Heart condition
47%
2+ chronic conditions
52%
1 chronic condition
68%
1+ chronic conditions
62%
No chronic condition
81%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
www.cowen.com
25
26
www.cowen.com
Ticker
Rating
Price*
Price Target
Ticker
Rating
Price*
Price Target
MDRX
CERN
MDAS
WBA
Outperform
Outperform
Outperform
Market Perform
$12.29
$71.26
$18.19
$77.10
$20.00
$76.00
$20.00
$74.00
ATHN
CVS
RAD
Outperform
Outperform
Outperform
$132.59
$102.62
$7.99
$172.00
$107.00
$10.00
*As of 02/19/2015
Investment Risks
Health Care IT:
There are potential risks associated with the HCIT space: (1) a significant amount
of spending on HCIT has been driven by government related programs (i.e., HITECH
Act), and any slowdown or cuts in such programs could negatively impact spending
on HCIT; (2) constrained hospital budgets could potentially lead to a decrease in
HCIT-related investments; (3) customer losses as a result of facility consolidation in
both the inpatient and outpatient markets could create challenges for a number of
vendors; (4) greater price competition in the HCIT industry; and (5) the current focus
on Meaningful Use incentives could delay purchasing decisions for non-EHR related
solutions and services.
Drug Retailers:
We see a number of risks associated with the drug retail space: (1) the industry
is highly competitive with retail drugstore chains, independent pharmacies, mailorder providers, as well as other retailers including grocery stores, mass merchants,
warehouse clubs and online stores all competing in the space which could further
pressure front-end sales and margins, (2) the current wave of drug patent expirations
and the positive impact on profitability derived from generics are expected to taper off
significantly over the next several years, (3) while specialty has provided a significant
tailwind for the most part we believe there could be some concerns around the
sustainability of high growth in this area, and (4) we believe the impact of PPACA
and the expected increase in volumes could be more subdued depending on the
implementation and execution.
www.cowen.com
27
Addendum
Analyst Certification
Each author of this research report hereby certifies that (i) the views expressed in the research report accurately reflect his or her personal views about any and all of the subject
securities or issuers, and (ii) no part of his or her compensation was, is, or will be related, directly or indirectly, to the specific recommendations or views expressed in this report.
Important Disclosures
This report constitutes a compendium report (covers six or more subject companies). As such, Cowen and Company, LLC chooses to provide specific disclosures for the companies
mentioned by reference. To access current disclosures for the all companies in this report, clients should refer to https://cowen.bluematrix.com/sellside/Disclosures.action or
contact your Cowen and Company, LLC representative for additional information.
Cowen and Company, LLC compensates research analysts for activities and services intended to benefit the firm's investor clients. Individual compensation determinations for
research analysts, including the author(s) of this report, are based on a variety of factors, including the overall profitability of the firm and the total revenue derived from all sources,
including revenues from investment banking. Cowen and Company, LLC does not compensate research analysts based on specific investment banking transactions.
Disclaimer
This research is for our clients only. Our research is disseminated primarily electronically and, in some cases, in printed form. Research distributed electronically is available
simultaneously to all Cowen and Company, LLC clients. All published research can be obtained on the Firm's client website, https://cowenlibrary.bluematrix.com/client/library.jsp.
Further information on any of the above securities may be obtained from our offices. This report is published solely for information purposes, and is not to be construed as an offer
to sell or the solicitation of an offer to buy any security in any state where such an offer or solicitation would be illegal. Other than disclosures relating to Cowen and Company, LLC,
the information herein is based on sources we believe to be reliable but is not guaranteed by us and does not purport to be a complete statement or summary of the available data.
Any opinions expressed herein are statements of our judgment on this date and are subject to change without notice.
For important disclosures regarding the companies that are the subject of this research report, please contact Compliance Department, Cowen and Company, LLC, 599 Lexington
Avenue, 20th Floor, New York, NY 10022. In addition, the same important disclosures, with the exception of the valuation methods and risks, are available on the Firm's disclosure
website at https://cowen.bluematrix.com/sellside/Disclosures.action.
Price Targets: Cowen and Company, LLC assigns price targets on all covered companies unless noted otherwise. The price target for an issuer's stock represents the value that
the analyst reasonably expects the stock to reach over a performance period of twelve months. The price targets in this report should be considered in the context of all prior
published Cowen and Company, LLC research reports (including the disclosures in any such report or on the Firm's disclosure website), which may or may not include price
targets, as well as developments relating to the issuer, its industry and the financial markets. For price target valuation methodology and risks associated with the achievement of
any given price target, please see the analyst's research report publishing such targets.
Notice to UK Investors: This publication is produced by Cowen and Company, LLC which is regulated in the United States by FINRA. It is to be communicated only to persons
of a kind described in Articles 19 and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. It must not be further transmitted to any other person
without our consent.
Copyright, User Agreement and other general information related to this report
2015 Cowen and Company, LLC. Member NYSE, FINRA and SIPC. All rights reserved. This research report is prepared for the exclusive use of Cowen clients and may not be
reproduced, displayed, modified, distributed, transmitted or disclosed, in whole or in part, or in any form or manner, to others outside your organization without the express prior
written consent of Cowen. Cowen research reports are distributed simultaneously to all clients eligible to receive such research reports. Any unauthorized use or disclosure is
prohibited. Receipt and/or review of this research constitutes your agreement not to reproduce, display, modify, distribute, transmit, or disclose to others outside your organization
the contents, opinions, conclusion, or information contained in this report (including any investment recommendations, estimates or price targets). All Cowen trademarks displayed
in this report are owned by Cowen and may not be used without its prior written consent.
Cowen and Company, LLC. New York (646) 562-1000 Boston (617) 946-3700 San Francisco (415) 646-7200 Chicago (312) 577-2240 Cleveland (440) 331-3531 Atlanta
(866) 544-7009 London (affiliate) 44-207-071-7500
COWEN AND COMPANY RATING DEFINITIONS
Cowen and Company Rating System effective May 25, 2013
Outperform (1): The stock is expected to achieve a total positive return of at least 15% over the next 12 months
Market Perform (2): The stock is expected to have a total return that falls between the parameters of an Outperform and Underperform over the next 12 months
Underperform (3): Stock is expected to achieve a total negative return of at least 10% over the next 12 months
Assumption: The expected total return calculation includes anticipated dividend yield
Cowen and Company Rating System until May 25, 2013
Outperform (1): Stock expected to outperform the S&P 500
Neutral (2): Stock expected to perform in line with the S&P 500
Underperform (3): Stock expected to underperform the S&P 500
Assumptions: Time horizon is 12 months; S&P 500 is flat over forecast period
Cowen Securities, formerly known as Dahlman Rose & Company, Rating System until May 25, 2013
Buy The fundamentals/valuations of the subject company are improving and the investment return is expected to be 5 to 15 percentage points higher than the general market
return
Sell The fundamentals/valuations of the subject company are deteriorating and the investment return is expected to be 5 to 15 percentage points lower than the general market
return
Hold The fundamentals/valuations of the subject company are neither improving nor deteriorating and the investment return is expected to be in line with the general market
return
28
www.cowen.com
Count
Ratings Distribution
Count
IB Services/Past 12 Months
Buy (a)
461
60.50%
109
23.64%
Hold (b)
288
37.80%
14
4.86%
Sell (c)
13
1.71%
0.00%
(a) Corresponds to "Outperform" rated stocks as defined in Cowen and Company, LLC's rating definitions. (b) Corresponds to "Market Perform" as defined in Cowen and Company,
LLC's ratings definitions. (c) Corresponds to "Underperform" as defined in Cowen and Company, LLC's ratings definitions.
Note: "Buy", "Hold" and "Sell" are not terms that Cowen and Company, LLC uses in its ratings system and should not be construed as investment options. Rather, these ratings
terms are used illustratively to comply with FINRA and NYSE regulations.
www.cowen.com
29
Points Of Contact
Analyst Profiles
Charles Rhyee
James Auh
Zachary Wachter
New York
New York
New York
646.562.1376
646.562.1352
646.562.1353
charles.rhyee@cowen.com
james.auh@cowen.com
zachary.wachter@cowen.com
Reaching Cowen
Main U.S. Locations
New York
Boston
Cleveland
San Francisco
Atlanta
Chicago
International Locations
Cowen International
Limited
London
Hong Kong
@CowenResearch
30